Waters Corp (WAT)

WAT (NYSE:Health Services) EQUITY
$157.40
pos +2.31
+1.49%
Today's Range: 154.58 - 158.00 | WAT Avg Daily Volume: 424,000
Last Update: 07/27/16 - 4:02 PM EDT
Volume: 773,423
YTD Performance: 15.24%
Open: $155.09
Previous Close: $155.09
52 Week Range: $112.00 - $159.46
Oustanding Shares: 80,941,488
Market Cap: 12,014,954,479
6-Month Chart
TheStreet Ratings Grade for WAT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 9 11 11 10
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.64 2.69 2.69 2.66
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 26.27
Price Earnings Comparisons:
WAT Sector Avg. S&P 500
26.27 26.30 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.31% 18.63% 54.84%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.70 0.10 0.03
Net Income 8.70 0.00 0.01
EPS 11.40 0.10 0.03
Earnings for WAT:
EBITDA 0.67B
Revenue 2.04B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $1.53 $2.14 $6.43 $6.98
Number of Analysts 9 8 11 10
High Estimate $1.62 $2.19 $6.65 $7.40
Low Estimate $1.49 $2.10 $6.30 $6.75
Prior Year $1.42 $1.96 $5.89 $6.43
Growth Rate (Year over Year) 7.98% 9.25% 9.21% 8.55%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Bearish
Apr 05, 2016 | 7:29 AM EDT
WAT was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. $137 price target. Company trades at a premium to its peers...
Bullish
Sep 10, 2015 | 7:41 AM EDT
WAT was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $140 price target. Stock has pulled back, but the company can...
Bullish
Jul 29, 2015 | 8:03 AM EDT
WAT was upgraded from Market Perform to Outperform, Wells Fargo said. Company's biopharma strength is sustainable. 
Remember: It's optional.
This solid niche manufacturing name offers high quality at a reasonable price. Here's how to get in.
Bearish
Oct 23, 2013 | 8:04 AM EDT
WAT was downgraded to Neutral from Buy, Bank of America/Merrill Lynch said. $105 price target. 2014 could be another rebuilding year fo...
Bearish
Oct 14, 2013 | 7:13 AM EDT
WAT was downgraded from Buy to Neutral, Mizuho said. $110 price target. See near-term choppiness in the pharmaceutical and diagnostic m...
Bullish
Jun 25, 2013 | 8:05 AM EDT
WAT was upgraded to Buy, Goldman Sachs said. $120 price target. Company is seeing better end-market demand. 

Early-Morning Market Look Real Money Pro($)

Let's take a peek at overnight and early-morning price action.
Bearish
Jan 17, 2013 | 8:08 AM EST
WAT was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call. 

Columnist Conversations

Markets in rally mode as Fed once again decides to leave rates unchanged in 9-1 vote.   Some big moves...
UPS will be reporting its 2nd quarter results before Friday's opening bell.  The stock has been fading si...
The FOMC essentially recycled the past couple of of policy statements at the conclusion of its two-day meeting...
we'll roll this to a higher strike, stock is breaking out. SOLD AGN SEP 250 CALL AT 14.40 (in at 9.30) B...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.